Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Privia Health is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-10-07SCHEDULE 13G/A
- SCHEDULE 13D2026-09-08SCHEDULE 13D
- 8-K2026-08-18Current report (material event)
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- SCHEDULE 13G/A2026-07-29SCHEDULE 13G/A
- 8-K2026-07-07Current report (material event)
- 8-K2026-05-22Current report (material event)
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-02Annual report to holders
- DEFA14A2026-04-02DEFA14A
- DEF 14A2026-04-02Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-27Annual report
- 8-K2026-02-26Current report (material event)
- 8-K2025-12-08Current report (material event)
- S-3ASR2025-11-06S-3ASR
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 8-K2025-10-28Current report (material event)
- SCHEDULE 13G/A2025-10-24SCHEDULE 13G/A
- 8-K2025-09-23Current report (material event)
- 8-K2025-08-29Current report (material event)
- SCHEDULE 13G2025-08-12SCHEDULE 13G
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- SCHEDULE 13G/A2025-08-06SCHEDULE 13G/A
- 8-K2025-07-08Current report (material event)
- 8-K2025-05-22Current report (material event)
- DEFA14A2025-05-12DEFA14A
- 10-Q2025-05-08Quarterly report
- 8-K2025-05-08Current report (material event)
- SCHEDULE 13G/A2025-04-28SCHEDULE 13G/A
- ARS2025-04-04Annual report to holders
- DEFA14A2025-04-04DEFA14A
- DEF 14A2025-04-04Proxy statement
- 8-K2025-03-07Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.